POS1054 PAIN AND DEPRESSION ARE ASSOCIATED WITH NON-RESPONSE TO METHOTREXATE IN PATIENTS WITH PSORIATIC ARTHRITIS

Autor: F. R. Kasiem, L. Tucker, M. Vis, J. Luime, I. Tchetverikov, K. Wervers, J. Hazes, L. Coates, M. R. Kok

Publikováno v: Annals of the Rheumatic Diseases. 81:847.1-847

BackgroundPsoriatic arthritis (PsA) is a heterogeneous, immune-mediated inflammatory arthritis. Methotrexate (MTX) is the first-line treatment in PsA patients, despite diverse clinical phenotypes and highly varied responses(1). As yet, it is not poss

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b8376b000bd69b4f320abf70fa49b1a
https://doi.org/10.1136/annrheumdis-2022-eular.2762

OP0129 REPORTED CONGENITAL MALFORMATIONS AFTER EXPOSURE TO NON-TNF-Α INHIBITORS: A RETROSPECTIVE COMPARATIVE STUDY IN EUDRAVIGILANCE DATABASE

Autor: N. Ghalandari, H. J. M. J. Crijns, J. Bergman, R. Dolhain, E. van Puijenbroek, J. Hazes

Publikováno v: Annals of the Rheumatic Diseases. 81:83.2-83

BackgroundTumor necrosis factor-α inhibitors (TNFis) such as certolizumab pegol (CZP), are a subgroup of biologics, which have shown no increase in risk of congenital malformations (CMs) after use during pregnancy. (1) However, for the subgroup of n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fea933f32b640d9dced2ce5f9646c13f
https://doi.org/10.1136/annrheumdis-2022-eular.864

FRI0110 TAPERING TOWARDS DMARD-FREE REMISSION IN ESTABLISHED RHEUMATOID ARTHRITIS: 2 YEAR RESULTS OF THE TARA TRIAL

Autor: E. Van Mulligen, A. Weel, M. Kuijper, J. Hazes, A. Van der Helm - van Mil, P. De Jong

Publikováno v: Annals of the Rheumatic Diseases. 79:635-636

Background:In rheumatoid arthritis (RA) disease outcomes have improved enormously in the last decades. Due to early initiation of therapy, a treat-to-target approach and a growing arsenal of disease-modifying antirheumatic drugs (DMARDs) and biologic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::016dc91fbeaca0a548cc550bd1bbd5e5
https://doi.org/10.1136/annrheumdis-2020-eular.1417

Additional file 1: of Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?

Autor: D. Ten Cate, J. Jacobs, W. Swen, J. Hazes, M. De Jager, N. Basoski, C. Haagsma, J. Luime, A. Gerards

Description of data: univariate and multivariate logistic regression in the multiple imputation dataset (Mâ =â 10) using STATA 12 and REALCOM. (DOC 44 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d3b1e8d7afe999c598e4ca7d0a5aaa1

Impact of triage by a rheumatologist on appropriateness of referrals from primary to secondary care: a cluster randomized trial.

Autor: van Delft E; Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands., Lopes Barreto D; Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands., Han KH; Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands., Tchetverikov I; Department of Rheumatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Evertse A; Medical Center Molenaar, Oud-Beijerland, The Netherlands., Kuijper TM; Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands., Hazes J; Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands., Weel-Koenders A; Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands.; Health Technology Assessment, Erasmus University, Rotterdam, The Netherlands.

Publikováno v: Scandinavian journal of rheumatology [Scand J Rheumatol] 2023 Jul; Vol. 52 (4), pp. 403-411. Date of Electronic Publication: 2022 Sep 29.